See more : Nostromo Energy Limited (NOST.TA) Income Statement Analysis – Financial Results
Complete financial analysis of PT Prodia Widyahusada Tbk (PRDA.JK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PT Prodia Widyahusada Tbk, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- Mayank Cattle Food Limited (MCFL.BO) Income Statement Analysis – Financial Results
- Meliá Hotels International, S.A. (SMIZF) Income Statement Analysis – Financial Results
- The Rank Group Plc (RANKF) Income Statement Analysis – Financial Results
- Oxbridge Re Holdings Limited (OXBRW) Income Statement Analysis – Financial Results
- iSelect Limited (ISU.AX) Income Statement Analysis – Financial Results
PT Prodia Widyahusada Tbk (PRDA.JK)
About PT Prodia Widyahusada Tbk
PT Prodia Widyahusada Tbk provides private clinical laboratory services. The company offers laboratory, panel test, and other diagnostics support services. As of December 31, 2021, it operated 259 outlets comprising 10 Prodia Health Care and specialty clinic outlets, 142 clinical lab and medical labs, 98 point of care outlets, and 9 hospital collaboration labs in 34 provinces throughout Indonesia. The company was founded in 1973 and is headquartered in Jakarta Pusat, Indonesia. PT Prodia Widyahusada Tbk is a subsidiary of PT Prodia Utama.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,222.47B | 2,181.64B | 2,652.26B | 1,873.38B | 1,744.27B | 1,599.76B | 1,466.02B | 1,358.66B | 1,197.73B | 1,101.04B | 997.99B |
| Cost of Revenue | 957.10B | 854.54B | 1,019.56B | 827.15B | 703.26B | 656.95B | 612.49B | 565.28B | 511.19B | 464.07B | 395.98B |
| Gross Profit | 1,265.37B | 1,327.11B | 1,632.70B | 1,046.22B | 1,041.01B | 942.81B | 853.53B | 793.38B | 686.53B | 636.98B | 602.01B |
| Gross Profit Ratio | 56.94% | 60.83% | 61.56% | 55.85% | 59.68% | 58.93% | 58.22% | 58.39% | 57.32% | 57.85% | 60.32% |
| Research & Development | 1.85B | 3.12B | 2.05B | 2.63B | 3.92B | 2.79B | 5.09B | 1.57B | 2.01B | 0.00 | 0.00 |
| General & Administrative | 888.60B | 269.93B | 304.01B | 237.56B | 288.11B | 257.37B | 244.69B | 27.99B | 25.40B | 27.17B | 22.79B |
| Selling & Marketing | 74.28B | 46.19B | 41.78B | 30.38B | 49.67B | 46.17B | 40.76B | 6.01B | 5.20B | 5.63B | 7.64B |
| SG&A | 962.88B | 316.12B | 345.79B | 267.94B | 337.78B | 303.53B | 285.45B | 34.00B | 30.60B | 32.80B | 30.43B |
| Other Expenses | -7.86B | 561.20B | 518.95B | 467.92B | 477.39B | 7.89B | 8.56B | 7.44B | 581.80B | 518.02B | 480.53B |
| Operating Expenses | 956.86B | 880.44B | 866.79B | 738.48B | 819.08B | 763.12B | 704.85B | 663.79B | 612.40B | 550.82B | 510.96B |
| Cost & Expenses | 1,913.97B | 1,734.97B | 1,886.34B | 1,565.63B | 1,522.34B | 1,420.06B | 1,317.33B | 1,229.08B | 1,123.60B | 1,014.89B | 906.94B |
| Interest Income | 34.35B | 26.05B | 33.48B | 42.48B | 52.07B | 47.67B | 55.45B | 5.15B | 649.91M | 1.35B | 314.12M |
| Interest Expense | 12.72B | 2.74B | 3.53B | 5.16B | 3.32B | 5.89B | 8.50B | 9.40B | 25.66B | 20.52B | 12.03B |
| Depreciation & Amortization | 136.10B | 146.88B | 145.34B | 139.25B | 80.63B | 76.47B | 59.65B | 45.99B | 36.29B | 30.67B | 26.19B |
| EBITDA | 478.95B | 629.26B | 948.89B | 490.77B | 357.08B | 311.36B | 272.71B | 182.65B | 131.80B | 121.48B | 120.12B |
| EBITDA Ratio | 21.55% | 27.39% | 34.44% | 24.61% | 19.32% | 18.14% | 17.21% | 12.12% | 7.40% | 10.19% | 11.33% |
| Operating Income | 308.50B | 447.04B | 756.63B | 301.76B | 216.05B | 179.92B | 149.76B | 129.60B | 96.94B | 90.81B | 93.93B |
| Operating Income Ratio | 13.88% | 20.49% | 28.53% | 16.11% | 12.39% | 11.25% | 10.22% | 9.54% | 8.09% | 8.25% | 9.41% |
| Total Other Income/Expenses | 30.40B | 23.31B | 29.95B | 37.31B | 48.75B | 41.78B | 46.96B | -4.25B | -19.95B | -14.52B | -6.37B |
| Income Before Tax | 338.90B | 470.35B | 786.58B | 339.08B | 264.80B | 221.69B | 196.71B | 120.20B | 76.99B | 76.29B | 87.56B |
| Income Before Tax Ratio | 15.25% | 21.56% | 29.66% | 18.10% | 15.18% | 13.86% | 13.42% | 8.85% | 6.43% | 6.93% | 8.77% |
| Income Tax Expense | 79.58B | 98.72B | 164.95B | 70.33B | 54.54B | 46.24B | 45.92B | 32.07B | 17.96B | 21.00B | 27.77B |
| Net Income | 259.87B | 371.65B | 623.23B | 268.75B | 210.26B | 175.45B | 150.80B | 88.13B | 59.02B | 58.56B | 61.59B |
| Net Income Ratio | 11.69% | 17.04% | 23.50% | 14.35% | 12.05% | 10.97% | 10.29% | 6.49% | 4.93% | 5.32% | 6.17% |
| EPS | 277.20 | 396.42 | 664.78 | 286.66 | 224.28 | 187.15 | 160.85 | 115.85 | 62.96 | 62.46 | 65.70 |
| EPS Diluted | 277.20 | 394.87 | 659.01 | 286.66 | 224.28 | 187.15 | 160.85 | 115.85 | 62.96 | 62.46 | 65.70 |
| Weighted Avg Shares Out | 937.50M | 937.50M | 937.50M | 937.50M | 937.50M | 937.50M | 937.50M | 760.79M | 937.50M | 937.50M | 937.50M |
| Weighted Avg Shares Out (Dil) | 937.50M | 941.19M | 945.70M | 937.50M | 937.50M | 937.50M | 937.50M | 760.79M | 937.50M | 937.50M | 937.50M |
Source: https://incomestatements.info
Category: Stock Reports